Glenmark Life Sciences (GLS) develops and manufactures a range of high-quality, industry-leading Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Leveraging our state-of-the-art laboratories and manufacturing locations, we supply over 130 molecules to more than 700 customers, which include the world's top 20 generic companies. From product selection & development to commercialization, we judiciously blend science, technology and economics to stay ahead of the curve. Our culture of environmental stewardship, responsible business practices and operational excellence makes us one of the most reliable and preferred partner in the industry. Our track record of regulatory compliance, cost advantage, speed and superior quality ensures business continuity for our customers spread over 65 countries, being one of the fastest growing API companies in the industry. Our revenue, historically generated from US and Europe, is rapidly expanding to new Emerging Geographies like South East Asia, Russia, Middle East, Japan and Latin America. Our people are our key differentiator. Our knowledgeable, responsible and inspired team, of over 1400 colleagues from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. For GLS employees, business is about relationships, hence we work as partners, who intend to preempt, meet and even exceed customer expectations. At GLS, we embrace an approach to business that lays equal amount of emphasis on generating value for the economy, environment and the society. GLS (www.glenmarklifesciences.com) was incorporated as an independent subsidiary of Glenmark Pharmaceuticals on January 1, 2019, to provide a strategic focus to the API business and help it unleash its full potential. Glenmark Pharmaceuticals (www.glenmarkpharma.com) is a 40 year-old integrated, research-driven, global pharmaceutical organization committed to enriching lives.